BD Max™ GBS 441772
by Becton, Dickinson and Company
Ref 441772
BD Max GBS 441772 is an in vitro diagnostic device (EU IVDR Class C; FDA Class I; EMDN category strep. b detection by na reagents) made by Becton, Dickinson and Company, registered in EUDAMED on 22 Sep 2026 (Basic UDI-DI 038290HDRXTDUXEX), cleared under FDA 510(k) K111860 on 16 Feb 2012 and listed in FDA GUDID since 19 May 2016 (UDI-DI 00382904417727), active as of 26 Oct 2026. 4 FDA recalls are linked to it.
Active
Valid until
No date given
FDA recalls
3 ongoingTrust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR EUDAMED | Number038290HDRXTDUXEX 00382904417727 | Date22 Sep 2026 | StatusActive |
| United States | GUDID listing GUDID | Number00382904417727 | Date19 May 2016 | StatusListed |
| United States | FDA 510(k)SESE GUDID | NumberK111860 | Date16 Feb 2012 | StatusActive |
Official records
- EUDAMED public site 038290HDRXTDUXEX
- AccessGUDID record 00382904417727
- FDA 510(k) database K111860
From the FDA record
- Device description
- BD MAX™ GBS
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI 038290HDRXTDUXEX registered 22 Sep 2026 Active
- FDA 510(k) K111860 decided 16 Feb 2012 Active
- FDA GUDID UDI-DI 00382904417727 listed 19 May 2016 Listed
Recalls
-
- Ongoing Z-0238-2026
Product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
- Ongoing Z-1004-2025
Potential for signal drift in specific lots of BD PCR Cartridges.
-
- Ongoing Z-0590-2025
BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
-
- Terminated Z-1864-2017
The BD MAX System software version 4.44A contains a software anomaly that has the potential to affect some Open System Reagent (OSR) customers utilizing User Defined Protocol (UDP) assays. Customers utilizing only IVD assays are not affected. This anomaly may cause the OSR customer system to incorrectly switch the columns of the truth table on the users display. If the user tries to fix their display data, the display will appear correct however, the database may become incorrect, potentially resulting in incorrect results reporting. BD is able to trace the issue to a limited number of instruments that have software version 4.44A installed. Note that the problem only affects customers that are either creating a new UDP with Result Logic or modifying the Result Logic of an existing UDP.
-
- Terminated Z-1662-2013
Electrical power module installed on some in vitro diagnostic instruments does not meet industry standards as labeled.
-
- Terminated Z-0976-2013
Cartridges are not sealing properly during PCR testing and may cause false results, indeterminates and/or invalid runs.
-
- Terminated Z-0701-2013
Clinical diagnostic instrument may exhibit minor defects, which could lead to erroneous test results.
Timeline
- Cleared FDA 510(k) K111860
- Recall initiated FDA recalls Z-0701-2013
- Recall initiated FDA recalls Z-0976-2013
- Recall initiated FDA recalls Z-1662-2013
- Recall initiated FDA recalls Z-1864-2017
- Listed FDA GUDID 00382904417727
- Recall initiated FDA recalls Z-0590-2025
- Recall initiated FDA recalls Z-1004-2025
- Recall initiated FDA recalls Z-0238-2026
- Registered EUDAMED 038290HDRXTDUXEX
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Max EUDAMEDBd Max™ Gbs GUDID
- Generic name
- Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
- Model / Ref / Catalog
- 441772
- Primary DI / UDI-DI
- 00382904417727
- Basic UDI-DI
- 038290HDRXTDUXEX
- 510(k) Number
- FDA product code
- NJR, OOI
- EMDN code
- W0105011104 Strep. b detection by na reagents
- GMDN term
- Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class C EUDAMEDClass I GUDID
- Regulation number
- 866.3740, 862.2570
- EU registration type
- Standard device
- EU market of registration
- Belgium
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class C | Class I |
Similar devices in this category
Other devices filed under STREP. B DETECTION BY NA REAGENTS.
- Simplexa™ GBS Direct MOL3550 MOL5290 by DiaSorin Molecular LLC
- Streptococcus Group B antisera by Genhawk (Wuhan) Biotech Co., Ltd.
- GBS Real-time PCR Kit HBRT-GBS by Chaozhou Hybribio Biochemistry Ltd.
- Panther Fusion® PRD-04484 by Hologic
- Group B Streptococcus Nucleic Acid Detection Kit (Real-Time PCR) 213601 by Yaneng BIOscience (Shenzhen) Co., Ltd.
- Group B Streptococcus DNA Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) S3056E by Sansure Biotech Inc.
- FlashDetect 6018027105-CE by Coyote Bioscience Co., Ltd.
- Strep B Rapid Test Cassette ISB-502 by Hangzhou Alltest Biotech.Co.,Ltd.
- PCR-based Group B Streptococcus Test Kit (Fluorometric PCR) ID020 by Beijing Applied Biological Technologies Co., Ltd.